News
It had pre-positioned remote-activated strike platforms inside Iran and deployed them with surgical precision. Israel’s ...
As the sole winner of the 2025 Culture Improvement Awards, the company's Concord plant cut mechanical downtime by over 50%, ...
An Oklahoma County judge has dismissed a lawsuit filed over the process used to approve controversial new social studies academic standards for Oklahoma students, saying the plaintiffs in the case ...
Avoid one of performance marketing’s biggest mistakes: misaligned CTAs. Align SEO and content with user intent at every stage of the funnel.
Recent analysis explores AI's momentum in drug development, showcasing rapid adoption and significant time savings, despite ...
A Diald AI webinar shows how AI can analyze real estate investments to uncover hidden essential factors that traditional data ...
A federal judge ordered the government to restore funding to hundreds of grants issued by the National Institutes of Health ...
Optimize airport operations using mid-term forecasts and real-time weather data to reduce delays, improve safety, and ...
The trickle-down effect of Trump's NIH budget cuts. Plus, Trump Organization launches a new mobile cell service. It's all on The Excerpt.
The number of households headed by same-sex couples in the U.S. has risen steadily, but they represent a small share of all ...
A white Heathcliff? A Black Snape? How casting directors getting book adaptations wrong with mindless race-swapping could ...
Using a recent survey on the adoption of AI/ML conducted by the Tufts CSDD as context, pharma leaders discussed how they are using these technologies to optimize trial execution.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results